Boston-based Brigham and Women’s Hospital and Melax Tech, a company specializing in natural language processing, have received a $2.5 million National Institutes of Health grant to develop a clinical decision-support tool for early detection of cognitive decline.
Read the full post on Becker's Hospital Review - Healthcare News
